The following stories appear in full on today's Vidyya Medical News Service Web site.
The UK Department of Health welcomes the advice issued on Friday by the
Committee on Safety of Medicines and the Joint Committee on
Vaccination and Immunization that MMR vaccine remains the safest way
to protect children.
For more information: MMR Vaccine Given Clean Bill Of Health
Over the last few months there have been a lot of TV and newspaper reports about MMR vaccine. This leaflet tries to give patients the facts behind the headlines.
For more information: MMR - The Facts
A product of the future will make its debut later this month. A telehealth technology innovator recently received clearance from the Food and Drug Administration (FDA) to market a Digital Electronic Weight Scale. The scale integrates with a family of products utilizing internet network technology to create two-way communications between chronically-ill patients and a network of healthcare providers using voice, video and data transfers. The scale provides the caregiver with an ability to detect changes in weight of chronically ill patients - an important indicator.
For more information: Internet Ready Digital Weight Scale Wins FDA
The first two women have been recruited to a British trial of a vaccine which could prevent cervical cancer. The trial, the first trial of its kind in the UK is being spearheaded by both the Cancer Research Campaign (CRC) and the Imperial Cancer Research Fund (ICRF). It comes as the CRC publishes a report on cervical cancer, which estimates there are over 3,000 new cases and 1,300 deaths from the disease in the UK every year.
For more information: British Trial Of Vaccine To Prevent Cervical Cancer Getting Underway
UK scientists have developed immune cells which can locate and destroy leukemia cells. The discovery could mean new treatments for the 18,000 people diagnosed every year in Britain with leukemia or related blood diseases.
New Leukemia Therapy On The Horizon
Today's Vidyya articles are:
As always, we hope you enjoy the issue.